Access. Intelligence. Excellence
APRIL 2015 Research Alert
|This month we added four new studies to the Best Practice Database, the research repository for Best Practices, LLC. Two of the new studies deliver benchmarks and insights on the quality function within the medical device sector. The device studies examine issues such as spend levels and M&A impact. The remaining two studies relate to the medical affairs function within biopharmaceutical companies and examine different aspects of how the function supports product launches. In particular, the studies focus on launch activities, thought leader targeting and investment levels. |
The new Best Practices, LLC studies listed below under Newly Added Research explore how leading companies have made their operations more effective across these different areas.
|Download: Benchmarking Medical Device Quality 2014-15: Current and Future Spend Levels (ID 5356)|
Best Practices, LLC undertook this study to explore how leading medical device companies are defining and allocating Quality spend, identifying factors that impact spending levels, and investing in future mission-critical Quality activities.
||Download: Medical Affairs Launch Support: Activities and Thought Leader Targeting (ID 5354) |
This benchmarking study identifies launch activities that Medical Affairs is currently involved with for product launches. In addition, the study includes metrics and insights around thought leader segmentation and MSL coverage.
||Download: Benchmarking Medical Device Quality 2014-15: M&A Impact and Improvement Approaches (ID 5357) |
This study explores the impact of M&A and integration efforts on the quality function as well as what types of programs quality leaders are using to improve their effectiveness.
|Download: Medical Affairs Launch Support: Budget and Activity Allocation (ID 5355)|
Best Practices, LLC undertook this benchmarking study to provide investment benchmarks for Medical Affairs launch support. Leading metrics and insights in the study include average launch investment for product support and Medical Affairs investment allocation.
ACCESS AND INTELLIGENCE FOR ACHIEVING WORLD-CLASS EXCELLENCE